BBOT Competitors & Alternatives
Compare BridgeBio Oncology Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
BBOT
Main Stock$2.85
Tradestie Score
53
Market Cap
$952.74M
Analyst Upside
+726.2%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$24.28
|
$256.54M | - | 53 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.66
|
$240.89M | - | 35 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.78
|
$231.77M | - | 48 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.95
|
$227.00M | - | 47 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.35
|
$211.22M | - | 46 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.83
|
$202.58M | - | 61 | Compare |
|
EVMN
EVMN
|
$5.21
|
$187.63M | - | 54 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$7.45
|
$170.45M | - | 42 | Compare |
More BBOT Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry